市場調査レポート

商品コード

1562480

免疫測定法の市場規模、シェア、成長分析、製品別、技術別、検体別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Immunoassay Market Size, Share, Growth Analysis, By Product, By Technology, By Specimen, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年09月14日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の免疫測定法の市場規模は、2022年に332億6,000万米ドルとなり、2023年の351億2,000万米ドルから、2031年までには542億7,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは5.59%で成長する見通しです。

世界の免疫測定法市場は、診断産業における重要なセクターであり、疾病検出、医薬品開発、臨床研究において極めて重要な役割を果たすことで評価されています。この市場は、慢性疾患の蔓延、早期診断ツールに対する需要の増加、アッセイ技術の進歩により大きく成長しています。同市場は、ELISA、ウェスタンブロッティング、ラジオ免疫測定法など多様な技術によって特徴付けられ、それぞれが様々な診断ニーズに対応しています。免疫測定法とバイオセンサーやナノテクノロジーなどの最先端技術との融合が、技術革新とアプリケーションの拡大を促進しています。さらに、個別化医療への注目の高まりと、迅速で正確かつ費用対効果の高い診断ソリューションへの需要が、市場の成長をさらに後押ししています。主要な企業は、アッセイの感度と特異性を高めるための研究開発に投資しており、市場の継続的な拡大と技術的進歩を位置づけています。

市場概要
試薬・キット
- ELISA試薬・キット
- 迅速検査試薬・キット
- ELISPOT試薬・キット
- CLIA試薬・キット
- IFA試薬・キット
- ウェスタンブロット試薬・キット
- その他の試薬・キット
アナライザー
- アナライザー、タイプ別
- オープンエンドシステム
- クローズドエンドシステム
- アナライザー、購入モード別
- レンタル購入
- 完全購入

免疫測定法市場：技術別

市場概要
ELISA
CLIA
IFA
迅速検査
ウエスタンブロッティング
ELISPOT
その他の技術

免疫測定法市場：検体別

市場概要
血液
唾液
尿
その他の検体

免疫測定法市場：用途別

市場概要
感染症
内分泌学
心臓病学
自己免疫疾患
アレルギー診断
腫瘍学
骨・ミネラル障害
薬物モニタリング・検査
血液検査
新生児スクリーニング
その他の用途

免疫測定法市場：エンドユーザー別

市場概要
病院・クリニック
臨床検査室
製薬・バイオテクノロジー企業・医薬品開発業務受託機関
在宅医療
血液銀行
研究・学術研究所

免疫測定法市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Abbott Laboratories（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Siemens Healthineers AG（Germany）
Danaher Corporation（US）
Thermo Fisher Scientific Inc.（US）
Revvity（US）
Becton, Dickinson and Company（US）
Diasorin S.p.A.（Italy）
Bio-Rad Laboratories, Inc.（US）
QuidelOrtho Corporation（US）
BioMerieux（France）
Qiagen N.V.（Netherlands）
Sysmex Corporation（Japan）
Agilent Technologies, Inc.（US）
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
Merck KGaA（Germany）
Meridian Bioscience（US）
Bio-Techne（US）
Cellabs（Australia）
Abnova Corporation（Taiwan）

Product Code: SQMIG35H2054

Global Immunoassay Market size was valued at USD 33.26 billion in 2022 and is poised to grow from USD 35.12 billion in 2023 to USD 54.27 billion by 2031, growing at a CAGR of 5.59% in the forecast period (2024-2031).

The global immunoassay market is a critical sector within the diagnostics industry, valued for its pivotal role in disease detection, drug development, and clinical research. This market has witnessed substantial growth due to the rising prevalence of chronic diseases, increased demand for early diagnostic tools, and advancements in assay technologies. The market is characterized by a diverse range of techniques, including ELISA, Western blotting, and radioimmunoassay, each catering to various diagnostic needs. The integration of immunoassays with cutting-edge technologies such as biosensors and nanotechnology is driving innovation and expanding applications. Moreover, the growing focus on personalized medicine and the demand for rapid, accurate, and cost-effective diagnostic solutions further fuel market growth. Key players are investing in research and development to enhance assay sensitivity and specificity, positioning the market for continued expansion and technological advancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoassay Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunoassay Market Segmental Analysis

Global Immunoassay Market is segmented on the basis of product, technology, specimen, application, end user, and region. By product, market is segmented into Reagents & Kits, Analyzers. By technology, market is segmented into ELISA, CLIA, IFA, Rapid Tests, Western Blotting, ELISPOT, and Other Technologies. By specimen, market is segmented into Blood, Saliva, Urine, and Other Specimens. By application, market is segmented into Infectious Diseases, Endocrinology, Cardiology, Autoimmune Disorders, Allergy Diagnostics, Oncology, Bone & Mineral Disorders, Drug Monitoring and Testing, Blood Screening, Newborn Screening, and Other Applications. By end user, market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations, Home Care Settings, Blood Banks, and Research & Academic Laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Immunoassay Market

One of the primary drivers of the immunoassay market is technological advancements. Innovations such as automated platforms, high-throughput screening, and the integration of artificial intelligence (AI) are significantly enhancing assay performance and efficiency. Automated systems streamline the process, reduce human error, and increase throughput, which is particularly beneficial in high-volume diagnostic settings. AI and machine learning algorithms are being utilized to interpret complex data sets, improving diagnostic accuracy and predictive capabilities. These technological improvements not only enhance the sensitivity and specificity of immunoassays but also reduce turnaround times and operational costs. The continual development of new assay formats and improvements in reagent formulations further drive the market by expanding the range of applications and enhancing overall performance.

Restraints in the Immunoassay Market

A significant restraint in the immunoassay market is the high cost associated with advanced assay systems. Sophisticated technologies, such as automated platforms and high-throughput systems, require substantial investment in terms of both initial capital and maintenance. The high costs of these systems can be prohibitive for smaller laboratories or healthcare facilities, potentially limiting their access to cutting-edge diagnostic tools. Additionally, the expense of high-quality reagents and consumables can further strain budgets. This financial barrier may hinder the adoption of advanced immunoassay technologies in emerging markets or in institutions with limited funding. Consequently, this restraint impacts the overall market growth by limiting the widespread implementation of the latest assay innovations.

Market Trends of the Immunoassay Market

A notable trend in the immunoassay market is the increasing adoption of point-of-care (POC) testing. This shift towards POC testing is driven by the need for rapid and convenient diagnostic solutions that can be administered outside traditional laboratory settings. POC immunoassays offer benefits such as immediate results, reduced need for sample transportation, and increased patient accessibility. They are particularly valuable in emergency situations, remote locations, and for monitoring chronic conditions. The development of compact, user-friendly devices with high sensitivity and specificity is fueling this trend. Additionally, advancements in microfluidics and biosensor technologies are enhancing the performance of POC assays, making them more reliable and effective. As healthcare systems seek to improve efficiency and patient outcomes, the demand for POC immunoassays is expected to continue rising.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Ecosystem of the Market
Top Investment Analysis
Key Success Factor
Degree of Competition
Regulatory Analysis
Technology Analysis
Trade Analysis
Patent Analysis
Value Chain Analysis
Supply Chain Analysis
Pricing Analysis

Immunoassay Market by Product

Market Overview
Reagents & Kits
- Elisa Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- CLIA Reagents & Kits
- IFA Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
Analyzers
- Analyzers, By Type
- Open-Ended Systems
- Closed-Ended Systems
- Analyzers, By Purchase Mode
- Rental Purchase
- Outright Purchase

Immunoassay Market by Technology

Market Overview
ELISA
CLIA
IFA
Rapid Tests
Western Blotting
ELISPOT
Other Technologies

Immunoassay Market by Specimen

Market Overview
Blood
Saliva
Urine
Other Specimens

Immunoassay Market by Application

Market Overview
Infectious Diseases
Endocrinology
Cardiology
Autoimmune Disorders
Allergy Diagnostics
Oncology
Bone & Mineral Disorders
Drug Monitoring and Testing
Blood Screening
Newborn Screening
Other Applications

Immunoassay Market by End User

Market Overview
Hospitals & Clinics
Clinical Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations
Home Care Settings
Blood Banks
Research & Academic Laboratories

Immunoassay Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diasorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellabs (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abnova Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments